TRENDING: Are AI Stocks Driving A Stock Market Tech Bubble? Here Are The Facts. Health care products giant McKesson's (MCK) stock broke out of a flat base Tuesday and jumped to a record high. It continued rising Wednesday. Last quarter Irving, Texas-based McKesson reported a 5% earnings gain to $8.26 per share on a 23% surge in revenue to $97.8 billion. Analyst consensus is for continued double-digit revenue growth the rest of this year, according to FactSet. McKesson Near Takeoff Point For Run Higher? Mean ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Wall Street paused on Tuesday after three straight sessions of strong gains that pushed major large-cap indices to fresh records.The S&P 500 slipped 0.2% to 6,682.62, while the Nasdaq 100 dipped 0.2%. The Dow Jones Industrial Average edged up 0.1% to 46,418.66, and small caps outperformed, with the Russell 2000 jumping 0.6%.PSKY shares are testing new highs. Get the complete picture here.On the economic front, the S&P Global U.S. Composite PMI slowed to 53.6 in September from 54.6 in August, signaling softe ...

McKesson (NYSE:MCK) 2025 Investor Day September 23, 2025 09:30 AM ET Speaker4Please take your seats and silence your mobile devices. The program will begin in five minutes.Speaker3Please take your seats.Speaker4The program will begin shortly.Speaker5It.Speaker1Today's presentation will include forward-looking statements. Please refer to the cautionary statements and to the risk factors of our most recent annual and periodic SEC filings for additional information concerning risk factors that could cause our ...

McKesson on Tuesday raised its profit forecast, as the U.S. drug distributor aims to focus on high-margin businesses such as cancer medicines to boost growth. ...

Advancing Health Outcomes for All® INVESTOR DAY | SEPTEMBER 23, 2025 Cautionary Statements Cautionary Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by their use of terminology such as "believes," "expects," "anticipates," "may," "will," "should," "seeks," "approximately," "intends," "projects," "plans," "estimates," "targets," ...

McKesson (NYSE:MCK) announced on Tuesday an improvement to its fiscal 2026 adjusted EPS guidance range to $38.05-$38.55 from $37.10-$37.90, vs. $37.48 consensus. Shares were +1.72% pre-market to $709.00. The healthcare services company is set to host its 2025 Investor Day today, beginning ...

核心观点 - 麦肯森公司作为美国医药分销行业主导企业 提供具有吸引力的风险回报特征 被市场低估 提供稳定现金流和高资本回报率 预计年化财富增长10-12% [2][3][4] 估值指标 - 股价报711.42美元 截至9月12日 追踪市盈率28.49倍 远期市盈率18.94倍 [1] - 自由现金流倍数仅16.5倍 同时收益以约13%年增长率增长 [3] - 投资1万美元可获得607美元所有者收益 预计以约8.6%速度复合增长 [4] 行业地位 - 处理美国约三分之一药品分销 是医疗保健领域关键"收费公路" [2] - 规模优势带来强大竞争护城河 定价能力和稳定现金流 [2] 增长动力 - 人口结构顺风确保持续需求增长 [3] - 战略转向更高利润的肿瘤服务 未来盈利能力将进一步加强 [3] 投资特性 - 提供抗衰退的医疗基础设施业务 具有强劲现金生成能力 [4] - 高资本回报率和结构性增长催化剂 [4] - 适合寻求稳定复利和资本保值的长期投资者 [4]